A Chinese hospital says Alibaba’s (BABA) PANDA AI tool has analyzed more than 180,000 CT scans to help doctors detect roughly 24 pancreatic cancer cases since its November 2024 rollout, The New York Times’ Vivian Wang reports. The tool was granted FDA breakthrough device status in April 2025 and is the subject of several clinical trials in China.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BABA:
- Alibaba’s Amaps to launch AI service for restaurants, Bloomberg reports
- Alibaba Stock Soars as Cloud and AI Bet Intensifies
- Private Markets: MiniMax secures Alibaba, Abu Dhabi investment
- Unusually active option classes on open January 2nd
- Pricey but Promising: 3 High P/E Ratio Stocks with Over 40% Upside in 2026